Lv11
32 积分 2024-11-28 加入
Next-generation JAK inhibitors in the treatment of myeloproliferative neoplasms
19分钟前
待确认
Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications
28天前
已完结
JAK inhibitor selectivity: new opportunities, better drugs?
29天前
已完结
Discovery of a Proteolysis-Targeting Chimera Degrader of JAK2 as a Potential Therapeutic Agent for JAK2-Mediated Myeloproliferative Neoplasms
3个月前
已完结
N-(Pyrimidin-2-yl)-1,2,3,4-tetrahydroisoquinolin-6-amine Derivatives as Selective Janus Kinase 2 Inhibitors for the Treatment of Myeloproliferative Neoplasms
3个月前
已完结
JAK inhibitor selectivity: new opportunities, better drugs?
6个月前
已完结
Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat Cancer
8个月前
已完结
Selective and Potent Molecular Glue Degraders for NIMA‐related Kinase 7
1年前
已完结
Selective degradation of multimeric proteins by TRIM21-based molecular glue and PROTAC degraders
1年前
已完结
Combination of ligand‑based and structure‑based virtual screening for the discovery of novel Janus kinase 2 inhibitors against philadelphia-negative myeloproliferative neoplasms
1年前
已完结
皖公网安备34019202002308
